Doses greater than 75 mg/d of antipsychotics significantly increased the risk of tardive dyskinesia, with odds ratios up to 3.5, according to a claims database study of corporate healthcare beneficiaries.
Key trial data and insights behind US Food and Drug Administration approvals of novel psychiatric drugs are shown, highlighting methods, demographics, and pivotal outcomes.
NIH director, Dr. Monica M. Bertagnolli, is stepping down after launching major initiatives in women's health and long COVID research, indicating optimism for their continuation under new leadership.
A new study exposes the alarming levels of medical and educational debt burdening U.S. health care workers, with debt disproportionately affecting women, Black workers, and those in lower-paying fields.
Conexiant
Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
A new Perturb-seq platform utilizes adeno-associated viruses vectors and transposons to examine cell-specific transcriptional networks within the developing brain in vivo.
Licensed therapist's untrained spouse impersonates her and provides therapy to hundreds of patients, unraveling a deception that resulted in license surrender and breach notification.
A recent study in JAMA Psychiatry reveals that socially vulnerable communities in the U.S. have higher rates of schizophrenia spectrum and substance use disorders, but receive less treatment for these conditions.